ACOTEC Scientific Holdings Limited reported no changes in its share structure for the month ended 31 July 2026.

The authorised share capital remained at 10 billion ordinary shares with a par value of USD 0.00001, corresponding to total authorised capital of USD 100,000.

Issued share capital was unchanged at 313.39 million ordinary shares, and the company continued to hold zero treasury shares.

No share options, warrants, convertible instruments, restricted share units or share award grants were exercised, issued or cancelled during the period. Consequently, there were no increases or decreases in either issued shares or treasury shares.

ACOTEC confirmed compliance with the Main Board’s minimum public-float requirement of 25 percent as at 31 July 2026.

The monthly return was submitted to Hong Kong Exchanges and Clearing Limited on 5 August 2026 and signed by Director Jing Li.